PB
BMY icon

Pinnacle Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Pinnacle Bancorp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$139K Hold
2,289
– – 0.04% 282
2025
Q4 		$123K Sell
2,289
-500
-18% -$24.1K 0.04% 298
2025
Q3 		$126K Hold
2,789
– – 0.04% 296
2025
Q2 		$129K Sell
2,789
-100
-3% -$4.91K 0.04% 289
2025
Q1 		$176K Sell
2,889
-287
-9% -$16.7K 0.06% 236
2024
Q4 		$180K Buy
3,176
+600
+23% +$33.5K 0.06% 231
2024
Q3 		$133K Hold
2,576
– – 0.04% 259
2024
Q2 		$107K Sell
2,576
-750
-23% -$33.6K 0.03% 267
2024
Q1 		$180K Buy
3,326
+565
+20% +$28.8K 0.05% 216
2023
Q4 		$142K Buy
2,761
+247
+10% +$13K 0.05% 229
2023
Q3 		$146K Sell
2,514
-950
-27% -$58.2K 0.05% 213
2023
Q2 		$222K Buy
3,464
+100
+3% +$6.71K 0.08% 178
2023
Q1 		$233K Hold
3,364
– – 0.09% 175
2022
Q4 		$242K Buy
3,364
+55
+2% +$4.15K 0.09% 165
2022
Q3 		$235K Sell
3,309
-102
-3% -$7.4K 0.1% 148
2022
Q2 		$263K Buy
3,411
+1,429
+72% +$109K 0.11% 134
2022
Q1 		$145K Buy
1,982
+146
+8% +$9.8K 0.05% 207
2021
Q4 		$114K Hold
1,836
– – 0.04% 232
2021
Q3 		$109K Buy
1,836
+174
+10% +$11.5K 0.04% 232
2021
Q2 		$111K Sell
1,662
-219
-12% -$14.3K 0.05% 228
2021
Q1 		$119K Sell
1,881
-45
-2% -$2.8K 0.06% 210
2020
Q4 		$119K Hold
1,926
– – 0.07% 206
2020
Q3 		$116K Sell
1,926
-185
-9% -$11.1K 0.08% 184
2020
Q2 		$124K Hold
2,111
– – 0.09% 175
2020
Q1 		$118K Hold
2,111
– – 0.1% 167
2019
Q4 		$136K Buy
2,111
+625
+42% +$35.8K 0.09% 176
2019
Q3 		$75K Sell
1,486
-522
-26% -$24.5K 0.04% 240
2019
Q2 		$91K Sell
2,008
-100
-5% -$4.66K 0.05% 219
2019
Q1 		$101K Sell
2,108
-609
-22% -$30.3K 0.06% 201
2018
Q4 		$141K Buy
+2,717
New +$146K 0.09% 160
2017
Q1 		$255K Buy
+4,694
New +$257K 0.18% 85

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Bancorp's BMY Position: Q1 2026 in Review

Pinnacle Bancorp held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 2,289 shares worth $139K. The position accounts for 0.04% of the portfolio, ranked #282.

Pinnacle Bancorp first reported a position in BMY in Q1 2017 and has held it in 31 quarters since. The position peaked at $263K in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Pinnacle Bancorp held 2,289 shares of Bristol-Myers Squibb worth $139K as of Q1 2026.
  • Pinnacle Bancorp left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.04% of Pinnacle Bancorp's portfolio in Q1 2026, its #282 holding.
  • Pinnacle Bancorp first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 31 quarters since.
  • Pinnacle Bancorp's Bristol-Myers Squibb position peaked at $263K in Q2 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Pinnacle Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.